Objective Coagulation and inflammatory parameters are mildly altered in children with SARS-CoV-2 (COVID-19) infection, and laboratory evidence of a proinflammatory and …
G Del Borrello, I Giraudo, C Bondone, M Denina… - Journal of thrombosis …, 2021 - Elsevier
Background Multiple investigators have described an increased incidence of thromboembolic events in SARS‐CoV‐2–infected individuals. Data concerning hemostatic …
Most children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have mild or minimal disease, with a small proportion developing severe disease or …
We report the clinical and laboratory coagulation characteristics of 27 pediatric and young adult patients (2 months to 21 years) treated for symptomatic COVID‐19 at a children's …
D Aguilera-Alonso, S Murias, AMA Garde… - Archives of disease in …, 2021 - adc.bmj.com
Knowledge of thrombosis in children with SARS-CoV-2 is scarce. In this multicentre national cohort of children with SARS-CoV-2 involving 49 hospitals, 4 patients out of 537 infected …
M Loi, B Branchford, J Kim, C Self… - Pediatric blood & …, 2020 - ncbi.nlm.nih.gov
To the Editor: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is often associated with hypercoagulability …
NA Goldenberg, A Sochet, M Albisetti… - … of Thrombosis and …, 2020 - Wiley Online Library
Background Observational studies indicate that children hospitalized with COVID‐19‐ related illness, like adults, are at increased risk for venous thromboembolism (VTE). A …
Since the initial description in 2019, the novel coronavirus SARS-Cov-2 infection (COVID- 19) pandemic has swept the globe. The most severe form of the disease presents with fever …
M Rieder, I Goller, M Jeserich, N Baldus… - Journal of thrombosis …, 2020 - Springer
COVID-19 is associated with a variety of clinical complications including coagulopathy, which frequently results in venous thromboembolism (VTE). Retrospective analyses …